Search

Displaying results 5661 - 5670 of 10000 in total
  1. Drug

    Semustine

    go.drugbank.com/drugs/DB13647
    Investigational

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
  2. Drug

    Proquazone

    go.drugbank.com/drugs/DB13649
    Experimental

    Categories: Heterocyclic Compounds, 2-Ring
  3. Drug

    Lorcainide

    go.drugbank.com/drugs/DB13653
    Experimental

    Categories: Antiarrhythmics, Class I, Heterocyclic Compounds, 1-Ring
  4. Drug

    Montmorillonite

    go.drugbank.com/drugs/DB13654
    Investigational

    Categories: Compounds used in a research, industrial, or household settingProducts: SMECTA SACHET 3 g/sachet, ENTEROVIAL® 3 G POLVO PARA RECONSTITUIR ASOLUCION ORAL.
  5. Drug

    Niridazole

    go.drugbank.com/drugs/DB13661
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Mosapramine

    go.drugbank.com/drugs/DB13676
    Experimental

    Categories: Heterocyclic Compounds, 2-Ring
  7. Drug

    Niaprazine

    go.drugbank.com/drugs/DB13687
    Investigational

    Niaprazine is a selective brain catecholamine depletor.

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Tritoqualine

    go.drugbank.com/drugs/DB13711
    Approved

    Categories: Heterocyclic Compounds, 2-Ring
  9. Drug

    Lebrikizumab

    go.drugbank.com/drugs/DB11914
    ApprovedInvestigational

    This approval is based on the positive results obtained from the Phase 3 studies ADvocate 1 and ADvocate 2, where nearly 80% of patients taking lebrikizumab either as monotherapy or combination therapy … Lebrikizumab is a monoclonal antibody that binds to IL-13 with high affinity and slow off-rate.[L51374] It binds to a different epitope compared [tralokinumab].

  10. Drug

    Guadecitabine

    go.drugbank.com/drugs/DB11918
    Investigational

    Guadecitabine is under investigation for the treatment of Previously Treated Metastatic Colorectal Cancer.

    Categories: Heterocyclic Compounds, 1-Ring